OasisLMS

Release Date: June 26, 2024

Expiration Date: June 25, 2027

This recorded webinar provides a practical introduction to dorsal root ganglion (DRG) stimulation, focusing on patient selection, education, and long-term management strategies. Led by physicians and advanced practice providers from high-volume DRG practices, the activity explores foundational concepts of DRG stimulation and highlights key considerations for integrating this therapy into clinical practice.

Through expert presentations and real-world insights, learners will gain a deeper understanding of how DRG stimulation differs from traditional dorsal column spinal cord stimulation, identify characteristics of appropriate candidates for therapy, and develop effective approaches to patient education and ongoing management. This activity is designed to equip clinicians with the knowledge and tools needed to optimize outcomes and enhance the patient experience throughout the DRG therapy journey.

To access the NANS eLearning Center and register for this content, log in using your NANS account username and password.

• Have a NANS account? Click Login.
• Need an account? Click Create Account and complete the form.
• Questions about your NANS account? Email membership@nans.org or call (773) 648-7845 (Mon–Fri, 8:30 AM–5:00 PM CT).

APPs in pain and neurosurgery as well as fellows.

Following participation in this activity, learners will be able to:

• Optimize patient selection for DRG.
• Describe the difference between dorsal column stimulation compared with dorsal root ganglion stimulation.
• Describe how to educate and manage patients that have DRG stimulation.

Welcome
Amy Yates, MSN, CNRN, AGNP-C & Patrick McGinn, PA

Dorsal Ganglion Stimulation - Patient Identification, Education and Management
Casey Grillo, APRN & Kenneth Chapman, MD

Dorsal Ganglion Stimulation
David Dickerson, MD & Brandon Johnson, PA-C

Conclusion
Amy Yates, MSN, CNRN, AGNP-C & Patrick McGinn, PA

None of the planners, staff, reviewers or faculty have any relevant financial relationships to disclose with ACCME ineligible companies except those listed below. All relevant relationships have been mitigated. 

Disclosures